Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Americas Silver Corporation Provides First Quarter Production and Cost Update

Published

on

Reading Time: 9 minutes

TORONTO–(BUSINESS WIRE)–Americas Silver Corporation (TSX: USA) (NYSE American: USAS) (“Americas
Silver” or the “Company”) today announced production and operating cost
results for the first quarter of 2019 on a consolidated basis and
individually for its Cosalá Operations and Galena Complex. All figures
are in U.S. dollars unless otherwise indicated.

First Quarter Highlights

  • Consolidated silver production of approximately 1.8 million silver
    equivalent1 ounces, an increase of 9% year-over-year, and
    395,000 silver ounces consistent with prior year.
  • Consolidated cash costs2 were approximately negative
    ($0.50) per silver ounce, a decrease of 144%, when compared to prior
    quarter. Consolidated all-in sustaining costs2 (“AISC”)
    were approximately $5.54 per silver ounce, a decrease of 53%, when
    compared to Q4 2018.
  • Milled tonnage at the Cosalá Operations increased by 24%
    year-over-year, with the San Rafael mine sustaining an average milling
    rate of approximately 1,750 tonnes per operating day. Production of
    approximately 1.3 million silver equivalent ounces including
    approximately 170,000 silver ounces, representing increases of 39% and
    118%, respectively, year-over-year. Cash costs were approximately
    negative ($30.48) per silver ounce and AISC were approximately
    negative ($25.85) per silver ounce representing decreases of 21% and
    130%, respectively, when compared to prior quarter.
  • Continuing operational challenges limited production at the Galena
    Complex to approximately 430,000 silver equivalent ounces including
    approximately 220,000 silver ounces, representing decreases of 15% and
    1%, respectively, when compared to prior quarter. Cash costs were
    approximately $23.03 per silver ounce and AISC were approximately
    $30.17 per silver ounce representing increases of 8% and 2%,
    respectively, when compared to prior quarter.
  • Subsequent to quarter end, the acquisition of Pershing Gold
    Corporation (“Pershing”) closed on April 3, 2019 after the Committee
    on Foreign Investment in the United States (“CFIUS”) completed its
    review. The Company announced concurrent financing signed with
    Sandstorm Gold Ltd. for gross proceeds of approximately US$42.5
    million to completely fund production at the Relief Canyon Project.
  • Guidance for 2019 remains unchanged at 1.6 – 2.0 million silver ounces
    and 6.6 – 7.0 million silver equivalent ounces at cash costs of $4.00
    to $6.00 per silver ounce and AISC of $10.00 to $12.00 per silver
    ounce. The Company expects to release its first quarter financial
    results on or before May 14, 2019.

“The Cosalá Operations had an excellent quarter mining and processing an
average of approximately 1,750 tonnes per operating day, resulting in
greater silver and by-product metal production, with lower cash costs
and AISC,” said Americas Silver President and CEO Darren Blasutti.
“Construction activity at Relief Canyon is ramping up and orders for
long-lead items have been placed as the Company advances this project
towards pouring gold before the end of the year. With the addition of
this new mine, the Company expects to increase precious metal production
by over 500% by 2021.”

Consolidated First Quarter Production Details

Consolidated silver production for the first quarter of 2019 was 393,824
ounces, which was largely consistent with both the prior quarter and
year-over-year. Silver equivalent production was approximately 1.8
million ounces, an increase of 9% year-over-year. Consolidated cash
costs decreased 144% to negative ($0.50) per silver ounce compared to
the prior quarter and increased 82% year-over-year, and AISC decreased
53% to $5.54 per silver ounce compared to the prior quarter and
decreased 10% year-over-year. Consolidated zinc production increased by
10% compared to the prior quarter and 54% year-over-year, while
consolidated lead production decreased by 10% compared to the prior
quarter and increased by 8% year-over-year.

 

 

Table 1
Consolidated Production Highlights

 

    Q1 2019   Q1 2018   Change   Q4 2018   Change
Processed Ore (tonnes milled)   182,029   163,875   11%   186,585   -2%
Silver Production (ounces)   393,824   397,035   -1%   395,294   -1%
Silver Equivalent Production (ounces)   1,754,839   1,613,711   9%   1,799,741   -2%
Silver Grade (grams per tonne)   87   95   -8%   87   0%
Cost of Sales ($ per equiv. ounce silver)   $7.11   $8.14   -13%   $7.87   -10%
Cash Costs ($ per ounce silver)   ($0.50)   ($2.73)   82%   $1.14   -144%
AISC ($ per ounce silver)   $5.54   $6.17   -10%   $11.78   -53%
Zinc Production (pounds)   11,263,623   7,332,978   54%   10,223,692   10%
Lead Production (pounds)   8,211,429   7,624,685   8%   9,088,862   -10%

Cosalá Operations Production Details

The Cosalá Operations produced 173,169 ounces of silver during the first
quarter of 2019 and 1,322,045 ounces of silver equivalent during the
same period at cash costs of negative ($30.48) per silver ounce and AISC
of negative ($25.85) per silver ounce. Silver production increased by
118% year-over-year and consistent with the fourth quarter 2018, while
silver equivalent production increased by 39% year-over-year and 3% over
the prior quarter. Cash costs and AISC improved by 21% and 130%,
respectively, compared to the Q4 2018.

 

Table 2
Cosalá Operations Highlights

 

    Q1 2019   Q1 2018   Change   Q4 2018   Change
Processed Ore (tonnes milled)   152,605   123,285   24%   149,577   2%
Silver Production (ounces)   173,169   79,382   118%   172,016   1%
Silver Equivalent Production (ounces)   1,322,045   948,081   39%   1,287,657   3%
Silver Grade (grams per tonne)   57   42   36%   59   -3%
Cost of Sales ($ per equiv. ounce silver)   $4.35   $5.92   -27%   $4.66   -7%
Cash Costs ($ per ounce silver)   ($30.48)   ($59.52)   -49%   ($25.12)   21%
AISC ($ per ounce silver)   ($25.85)   ($36.28)   -29%   ($11.26)   130%
Zinc Production (pounds)   11,263,623   7,332,978   54%   10,223,692   10%
Lead Production (pounds)   4,626,233   2,679,485   73%   4,388,146   5%

Strong results were driven by sustained improvements in grade, mill
throughput and metal recovery to concentrate. Site expenditures tracked
expectations. Development of the incline ramp toward San Rafael’s Upper
Zone has resumed and is advancing ahead of plan. Ore production from the
Main Zone benefited from the additional working headings providing
operational flexibility. Further, mined head grades exceeded budgeted
head grades during the quarter. Any potential reduction in head grades
over the remainder of the year are expected to be largely offset by
further gains in mill throughput and metal recovery as additional
flotation capacity is installed during the second quarter.

Galena Complex Production Details

Unplanned mill downtime due to problems with the mill pinion bearing at
the Galena mine in January set the year off on a challenging note
however the underlying issues were successfully resolved during the
quarter. Performance trended back up until two separate ground falls
delayed production from two high-tonnage stopes. The cumulative impact
was the loss of nearly one month’s production during the quarter.
Performance is slowly improving and should return to expected levels by
the end of Q2 2019. Management remains committed to returning the
operation to an acceptable level of performance.

As a result of these unexpected incidents, the Galena Complex produced
220,655 ounces of silver during Q1 2019 and 432,794 ounces of silver
equivalent at cash costs of $23.03 per silver ounce and AISC of $30.17
per silver ounce. Silver and silver equivalent production decreased by
1% and 15%, respectively, compared to the prior quarter, and 31% and
35%, respectively, year-over-year. Cash costs and AISC increased by 8%
and 2%, respectively, due to the noted operational challenges.

 

Table 3
Galena Complex Highlights

 

    Q1 2019   Q1 2018   Change   Q4 2018   Change
Processed Ore (tonnes milled)   29,424   40,590   -28%   37,008   -20%
Silver Production (ounces)   220,655   317,653   -31%   223,278   -1%
Silver Equivalent Production (ounces)   432,794   665,630   -35%   512,084   -15%
Silver Grade (grams per tonne)   242   256   -5%   199   22%
Cost of Sales ($ per equiv. ounce silver)   $15.55   $11.31   38%   $15.95   -2%
Cash Costs ($ per ounce silver)   $23.03   $11.46   101%   $21.36   8%
AISC ($ per ounce silver)   $30.17   $16.78   80%   $29.52   2%
Lead Production (pounds)   3,585,196   4,945,200   -28%   4,700,716   -24%

Relief Canyon Update

On April 3, 2019, the Company announced the closing of the Pershing
acquisition after receiving notification that CFIUS completed its
review. The Company also announced a financing package of $42.5 million
secured from Sandstorm Gold Ltd. to fully fund the development of Relief
Canyon and Board approval for construction commencement at the Project
with the intention of pouring gold before year end. Since that time,
orders have been placed for long-lead items such as the mill liners,
crusher and conveyor system and negotiations have commenced on the leach
pad construction and mining contracts. Expected start dates are mid-May
and mid-June respectively. Further information on the Relief Canyon
development will be made available periodically on the Company’s website
as construction progresses at www.americassilvercorp.com.

Americas Silver Annual and Special Meeting

The annual and special meeting of Americas Silver is scheduled for 3pm
(EDT) on Wednesday May 15, 2019 at Vantage Venues, 150 King St. West,
Toronto, Ontario.

Your vote is important. Please vote before the proxy vote deadline on
May 13, 2019 at 3pm (EDT).

Additional information concerning the annual and special meeting can be
found in the Management Information Circular dated April 18, 2019. An
electronic copy of the Circular is available online under the Company’s
profile at www.sedar.com
or at www.americassilvercorp.com.

About Americas Silver Corporation

Americas Silver is a precious metal mining company focused on growth
from its existing asset base and execution of targeted accretive
acquisitions. It owns and operates the Cosalá Operations in Sinaloa,
Mexico and the Galena Complex in Idaho, USA. The Company expects to
begin producing gold in the fourth quarter of 2019 at its fully-funded
Relief Canyon Project, in Nevada, USA which is currently in
construction. For further information, please see SEDAR or
americassilvercorp.com.

Cautionary Statement on Forward-Looking Information:

This news release contains “forward-looking information” within the
meaning of applicable securities laws. Forward-looking information
includes, but is not limited to, Americas Silver’s expectations,
intentions, plans, assumptions and beliefs with respect to, among other
things, Americas Silver’s financing efforts; construction, production,
and development plans at the Relief Canyon Project and performance
expectations for the Relief Canyon Project and impact on Americas
Silver’s financial performance; and the estimated construction timeline
and costs for the Relief Canyon Project; the estimated timeline for
environmental approvals for the second phase of the Relief Canyon
Project; and the impact of the Transaction on the liquidity of the
Company’s shares. Often, but not always, forward-looking information can
be identified by forward-looking words such as “anticipate”, “believe”,
“expect”, “goal”, “plan”, “intend”, “potential’, “estimate”, “may”,
“assume” and “will” or similar words suggesting future outcomes, or
other expectations, beliefs, plans, objectives, assumptions, intentions,
or statements about future events or performance. Forward-looking
information is based on the opinions and estimates of Americas Silver as
of the date such information is provided and is subject to known and
unknown risks, uncertainties, and other factors that may cause the
actual results, level of activity, performance, or achievements of
Americas Silver to be materially different from those expressed or
implied by such forward-looking information. With respect to the
Sandstorm financing, risks and uncertainties include the ability of the
Company and its subsidiaries to fulfill the conditions to drawing all
the available funds under the purchase agreement and convertible
debenture and the potential for, and consequences of, default
thereunder. With respect to the business of Americas Silver, these risks
and uncertainties include interpretations or reinterpretations of
geologic information; unfavorable exploration results; inability to
obtain permits required for future exploration, development or
production; general economic conditions and conditions affecting the
industries in which the Company operates; the uncertainty of regulatory
requirements and approvals; fluctuating mineral and commodity prices;
the ability to obtain necessary future financing on acceptable terms or
at all; the ability to develop, complete construction and operate the
Relief Canyon Project; and risks associated with the mining industry
such as economic factors (including future commodity prices, currency
fluctuations and energy prices), ground conditions and other factors
limiting mine access, failure of plant, equipment, processes and
transportation services to operate as anticipated, environmental risks,
government regulation, actual results of current exploration and
production activities, possible variations in ore grade or recovery
rates, permitting timelines, capital and construction expenditures,
reclamation activities, labor relations, social and political
developments and other risks of the mining industry. Although the
Company has attempted to identify important factors that could cause
actual results to differ materially from those contained in
forward-looking information, there may be other factors that cause
results not to be as anticipated, estimated, or intended. Readers are
cautioned not to place undue reliance on such information. Additional
information regarding the factors that may cause actual results to
differ materially from this forward‐looking information is available in
Pershing Gold’s filings with the SEC, including the Annual Report on
Form 10‐K for the year ended December 31, 2017 and the Proxy Statement
of Pershing Gold dated November 29, 2018, and in Americas Silver’s
filings with the Canadian Securities Administrators on SEDAR and with
the SEC, including the management information circular of Americas
Silver dated December 4, 2018. Americas Silver does not undertake any
obligation to update publicly or otherwise revise any forward-looking
information whether as a result of new information, future events or
other such factors which affect this information, except as required by
law. Americas Silver does not give any assurance (1) that Americas
Silver will achieve its expectations, or (2) concerning the result or
timing thereof. All subsequent written and oral forward‐looking
information concerning Americas Silver, the Transaction, the Sandstorm
financing package, the combined Company or other matters attributable to
Americas Silver or any person acting on its behalf are expressly
qualified in their entirety by the cautionary statements above.

1 Silver equivalent production throughout this press release
was calculated based on silver, zinc, and lead realized prices during
each respective period.

2 Cash cost per ounce and all-in sustaining cost per ounce
are non-IFRS performance measures with no standardized definition. For
further information and detailed reconciliations, please refer to the
Company’s 2018 year-end and quarterly MD&A. The performance measures for
the quarter ended March 31, 2019 are preliminary throughout this press
release subject to refinement from the Company’s first quarter financial
results to be released on or before May 14, 2019.

Contacts

Darren Blasutti
President and CEO
Americas Silver Corporation
416‐848‐9503


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Medical Cannabis Market Report 2024-2030: Asia-Pacific Set to Witness Robust Growth, Driven by R&D Discovery Initiatives

Published

on

Continue Reading

Cannabis

Rubicon Organics Reports Q1 2024 Financial Results

Published

on

Continue Reading

SCHWAZZE

Schwazze Announces First Quarter 2024 Financial Results

Published

on

schwazze-announces-first-quarter-2024-financial-results

Schwazze Management to Host Conference Call Today at 5:00 p.m. Eastern Time

DENVER, May 15, 2024 /PRNewswire/ — Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) (“Schwazze” or the “Company”), today announced financial and operational results for the first quarter ended March 31, 2024.

“We delivered another period of revenue growth in Q1 as we further refined our retail strategy while contending with the prolonged competitive challenges in Colorado and New Mexico,” said Forrest Hoffmaster, Interim CEO of Schwazze. “Throughout the quarter, we continued to sharpen our pricing and promotional efforts while enhancing the in-store experience, widening assortment, improving in-stock position, and advancing our loyalty program to attract and retain new customers. We also strengthened our wholesale business with quarter-over-quarter growth, while surpassing 30% total door penetration across both states.”

“The Colorado market remains highly competitive with more than 680 active recreational licenses, underscoring the importance of delivering an exceptional customer experience and fully integrated retail support program. Although retail pricing has recently stabilized, Colorado sales in Q1 were down 10% year-over-year due to lower volumes. Nonetheless, we significantly outpaced the market as our sales were up 9%, demonstrating the effectiveness of our operating playbook to compete in challenging environments. We expect to continue driving improvements in customer acquisition, retention, and loyalty as we further increase market share in the state.”

“In New Mexico, the proliferation of new licenses continued to outpace state cannabis sales as store count in Q1 increased 31% year-over-year while the market grew only 13%. In addition to pricing and promotional efforts, we’ve focused on driving traffic into our stores by expanding assortment with high quality flower and delivering an elevated customer experience. The New Mexico regulatory body has also increased its license enforcement efforts in recent months, contributing to more than 70 store closures and a 33% sequential decrease in net new store openings in the first quarter. We will continue to support the New Mexico Cannabis Control Division as it develops its regulatory framework.”

“Over the past four years we have rapidly scaled our footprint through 13 acquisitions, building a leading retail presence in both Colorado and New Mexico. We are beginning to see positive momentum from our pricing and promotional strategy and will remain focused on driving operating efficiencies while further optimizing our assets as we consolidate cultivation facilities and eliminate underperforming stores that do not meet our high-margin thresholds. We believe these initiatives, coupled with our operating playbook and strict cost controls, will enable us to return to stronger levels of profitability moving forward.”

First Quarter 2024 Financial Summary

$ in Thousands USD

Q1 2024

Q4 2023

Q1 2023

Total Revenue

$41,601

$43,325

$40,001

Gross Profit

$17,934

$7,034[1]

$21,849

Operating Expenses

$20,643

$23,276

$16,199

Income (Loss) from Operations

$(2,709)

$(16,242)

$5,650

Adjusted EBITDA[2]

$7,341

$10,953

$14,525

Operating Cash Flow

$(3,700)

$3,452

$(880)

Recent Highlights

  • Announced the grand opening of a medical and recreational dispensary in March under the Everest Apothecary banner in Las Cruces, New Mexico, increasing the Company’s retail footprint to 34 stores across the state.
  • Increased wholesale penetration in the first quarter to more than 30% of total doors in Colorado and New Mexico.
  • Lowell Herb Co. pre-roll sales increased more than 3x quarter-over-quarter in Colorado, where it continues to be the #1 pre-roll in the state.
  • Wana gummy sales up more than 2x quarter-over-quarter in New Mexico.

First Quarter 2024 Financial Results

Total revenue in the first quarter of 2024 increased 4% to $41.6 million compared to $40.0 million for the same quarter last year. The increase was primarily due to growth from new stores compared to the prior year period, partially offset by continued pricing pressure and the proliferation of new licenses in New Mexico.

Gross profit for the first quarter of 2024 was $17.9 million or 43.1% of total revenue, compared to $21.8 million or 54.6% of total revenue for the same quarter last year. The decrease in gross margin was primarily driven by the aforementioned pricing pressure in New Mexico, as well as higher medical sales mix in Colorado.

____________________________

1 Q4 2023 Gross Profit includes one-time, non-cash inventory adjustments of approximately $13.1 million comprised of $3.1 million of product consolidation, obsolescence, and shrinkage expenses, $4.3 million of net realizable value adjustments, and $5.8 million of fair value adjustments on acquired inventory in New Mexico in 2023. 
2  Adjusted EBITDA is a non-GAAP measure as defined by the SEC, and represents earnings before interest, taxes, depreciation, and amortization, adjusted for other income, non-cash share-based compensation, one-time transaction related expenses, or other non-operating costs. The Company uses Adjusted EBITDA as it believes it better explains the results of its core business. See “ADJUSTED EBITDA RECONCILIATION (NON-GAAP)” section herein for an explanation and reconciliations of non-GAAP measure used throughout this release.

Operating expenses for the first quarter of 2024 were $20.6 million compared to $16.2 million for the same quarter last year. The year-ago period benefitted from a payroll tax credit of $3.9M. The remaining increase was primarily driven by personnel expenses and four-wall SG&A costs associated with 21 additional stores in Colorado and New Mexico that are still ramping.

Loss from operations for the first quarter of 2024 was $2.7 million compared to income from operations of $5.6 million in the same quarter last year. Net loss was $16.1 million for the first quarter of 2024 compared to net income of $1.7 million for the same quarter last year.

Adjusted EBITDA for the first quarter of 2024 was $7.3 million compared to $14.5 million for the same quarter last year. The decrease in Adjusted EBITDA was primarily driven by lower gross margin and higher operating expenses associated with the 21 additional stores that are still ramping.

As of March 31, 2024, cash and cash equivalents were $13.2 million compared to $19.2 million on December 31, 2023. Total debt as of March 31, 2024, was $159.7 million compared to $156.8 million on December 31, 2023.

Conference Call

The Company will conduct a conference call today, May 15, 2024, at 5:00 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2024.

Schwazze management will host the conference call, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call by emailing [email protected].

Date: Wednesday, May 15, 2024
Time: 5:00 p.m. Eastern time
Toll-free dial-in: (888) 664-6383
International dial-in: (416) 764-8650
Conference ID: 84167910
Webcast: SHWZ Q1 2024 Earnings Call

The conference call will also be broadcast live and available for replay on the investor relations section of the Company’s website at https://ir.schwazze.com.

Toll-free replay number: (888) 390-0541
International replay number: (416) 764-8677
Replay ID: 167910

If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.

About Schwazze

Schwazze (OTCQX: SHWZ) (Cboe CA: SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to explore taking its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale.

Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector.

Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc. Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth. To learn more about Schwazze, visit https://schwazze.com/.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include financial outlooks; any projections of net sales, earnings, or other financial items; any statements of the strategies, plans and objectives of our management team for future operations; expectations in connection with the Company’s previously announced business plans; any statements regarding future economic conditions or performance; and statements regarding the intent, belief or current expectations of our management team. Such statements may be preceded by the words “may,” “will,” “could,” “would,” “should,” “expect,” “intends,” “plans,” “strategy,” “prospects,” “anticipate,” “believe,” “approximately,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other words of similar meaning in connection with a discussion of future events or future operating or financial performance, although the absence of these words does not necessarily mean that a statement is not forward-looking. We have based our forward-looking statements on management’s current expectations and assumptions about future events and trends affecting our business and industry. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. Therefore, forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) regulatory limitations on our products and services and the uncertainty in the application of federal, state, and local laws to our business, and any changes in such laws; (ii) our ability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (iii) our ability to identify, consummate, and integrate anticipated acquisitions; (iv) general industry and economic conditions; (v) our ability to access adequate capital upon terms and conditions that are acceptable to us; (vi) our ability to pay interest and principal on outstanding debt when due; (vii) volatility in credit and market conditions; (viii) the loss of one or more key executives or other key employees; and (ix) other risks and uncertainties related to the cannabis market and our business strategy. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.

Investor Relations Contact
Sean Mansouri, CFA or Aaron D’Souza
Elevate IR
(720) 330-2829
[email protected]

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
For the Periods Ended March 31, 2024 and December 31, 2023
Expressed in U.S. Dollars

 March 31,

December 31, 

2024

2023

 

ASSETS

 

Current Assets

Cash & Cash Equivalents

$

13,151,317

$

19,248,932

Accounts Receivable, net of Allowance for Doubtful Accounts

3,356,032

4,261,159

Inventory

26,382,184

25,787,793

Marketable Securities, net of Unrealized Loss of $347,516 and Loss of $1,816, respectively

108,583

456,099

Prepaid Expenses & Other Current Assets

3,502,310

3,914,064

Total Current Assets

46,500,426

53,668,047

Non-Current Assets

Fixed Assets, net Accumulated Depreciation of $10,061,700 and $8,741,782, respectively

31,326,000

31,113,630

Investments

2,000,000

2,000,000

Investments Held for Sale

202,111

Goodwill

67,492,705

67,499,199

Intangible Assets, net Accumulated Amortization of $36,483,160 and $32,706,765, respectively

162,391,482

166,167,877

Other Non-Current Assets

1,328,187

1,263,837

Operating Lease Right of Use Assets

34,575,832

34,233,142

Deferred Tax Assets, net

992,144

1,996,489

Total Non-Current Assets

300,106,350

304,476,285

Total Assets

$

346,606,776

$

358,144,332

 

LIABILITIES & STOCKHOLDERS’ EQUITY

 

Current Liabilities

Accounts Payable

$

9,443,233

$

13,341,561

Accrued Expenses

8,106,618

7,774,691

Derivative Liabilities

1,319,845

638,020

Lease Liabilities – Current

5,186,316

4,922,724

Current Portion of Long Term Debt

29,579,713

3,547,011

Income Taxes Payable

28,235,039

25,232,782

Total Current Liabilities

81,870,764

55,456,789

Non-Current Liabilities

Long Term Debt, net of Debt Discount & Issuance Costs

130,120,753

153,262,203

Lease Liabilities – Non-Current

30,735,072

30,133,452

Total Non-Current Liabilities

160,855,825

183,395,655

Total Liabilities

$

242,726,589

$

238,852,444

Stockholders’ Equity

Preferred Stock, $0.001 Par Value. 10,000,000 Shares Authorized; 82,185 Shares Issued and

82,185 Outstanding as of March 31, 2024 and 85,534 Shares Issued and 85,534 Outstanding as of

December 31, 2023.

82

86

Common Stock, $0.001 Par Value. 250,000,000 Shares Authorized; 79,168,539 Shares Issued

and 78,248,389 Shares Outstanding as of March 31, 2024 and 74,888,392 Shares Issued

and 73,968,242 Shares Outstanding as of December 31, 2023.

79,169

74,888

Additional Paid-In Capital

202,677,665

202,040,968

Accumulated Deficit

(96,843,602)

(80,790,927)

Common Stock Held in Treasury, at Cost, 920,150 Shares Held as of March 31, 2024 and

920,150 Shares Held as of December 31, 2023.

(2,033,127)

(2,033,127)

Total Stockholders’ Equity

103,880,187

119,291,888

Total Liabilities & Stockholders’ Equity

$

346,606,776

$

358,144,332

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME AND (LOSS)
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

(Unaudited)

(Unaudited)

Operating Revenues

Retail

$

37,633,252

$

35,820,111

Wholesale

3,898,320

4,058,925

Other

69,421

121,900

Total Revenue

41,600,993

40,000,936

Total Cost of Goods & Services

23,667,319

18,152,163

Gross Profit

17,933,674

21,848,773

Operating Expenses

Selling, General and Administrative Expenses

11,835,818

10,100,934

Professional Services

1,671,881

1,187,364

Salaries

6,880,988

4,695,971

Stock Based Compensation

253,916

214,544

Total Operating Expenses

20,642,603

16,198,813

Income from Operations

(2,708,929)

5,649,960

Other Income (Expense)

Interest Expense, net

(8,307,369)

(7,745,854)

Unrealized Gain (Loss) on Derivative Liabilities

(681,825)

8,501,685

Other Loss

10,500

Loss on Investment

(33,382)

Unrealized Gain on Investment

(347,516)

1,816

Total Other Income (Expense)

(9,359,592)

757,647

Pre-Tax Net Income (Loss)

(12,068,521)

6,407,607

Provision for Income Taxes

3,984,154

4,662,178

Net Income (Loss)

$

(16,052,675)

$

1,745,429

Less: Accumulated Preferred Stock Dividends for the Period

(2,155,259)

(2,029,394)

Net Income (Loss) Attributable to Common Stockholders

$

(18,207,934)

$

(283,965)

Earnings (Loss) per Share Attributable to Common Stockholders

Basic Earnings (Loss) per Share

$

(0.24)

$

(0.01)

Diluted Earnings (Loss) per Share

$

(0.24)

$

(0.06)

Weighted Average Number of Shares Outstanding – Basic

76,006,932

55,835,501

Weighted Average Number of Shares Outstanding – Diluted

76,006,932

101,608,278

Comprehensive Income (Loss)

$

(16,052,675)

$

1,745,429

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

(Unaudited)

(Unaudited)

Cash Flows from Operating Activities:

Net Income (Loss) for the Period

$

(16,052,675)

$

1,745,429

Adjustments to Reconcile Net Income (Loss) to Cash for Operating Activities

Depreciation & Amortization

5,096,314

6,151,395

Non-Cash Interest Expense

1,031,431

991,184

Non-Cash Lease Expense

2,871,226

2,251,459

Deferred Taxes

1,004,345

(637,225)

Loss on Investment

202,111

Change in Derivative Liabilities

681,825

(8,501,685)

Amortization of Debt Issuance Costs

421,512

421,513

Amortization of Debt Discount

2,303,246

1,999,933

(Gain) Loss on Investments, net

347,516

(1,816)

Stock Based Compensation

640,974

214,544

Changes in Operating Assets & Liabilities (net of Acquired Amounts):

Accounts Receivable

905,127

(118,181)

Inventory

(587,900)

(3,023,251)

Prepaid Expenses & Other Current Assets

411,754

(3,036,801)

Other Assets

(64,350)

360,674

Change in Operating Lease Liabilities

(2,348,703)

(1,531,765)

Accounts Payable & Other Liabilities

(3,566,401)

(3,464,671)

Income Taxes Payable

3,002,257

5,299,403

Net Cash Provided by (Used in) Operating Activities

(3,700,390)

(879,861)

Cash Flows from Investing Activities:

Collection of Notes Receivable

10,631

Purchase of Fixed Assets

(1,532,287)

(2,913,394)

Net Cash Provided by (Used in) Investing Activities

(1,532,287)

(2,902,763)

Cash Flows from Financing Activities:

Payment on Notes Payable

(864,938)

Net Cash Provided by (Used in) Financing Activities

(864,938)

Net (Decrease) in Cash & Cash Equivalents

(6,097,615)

(3,782,624)

Cash & Cash Equivalents at Beginning of Period

19,248,932

38,949,253

Cash & Cash Equivalents at End of Period

$

13,151,317

$

35,166,628

Supplemental Disclosure of Cash Flow Information:

Cash Paid for Interest

$

4,515,205

$

6,540,748

MEDICINE MAN TECHNOLOGIES, INC.
ADJUSTED EBITDA RECONCILIATION (NON-GAAP)
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

Net Income (Loss)

$

(16,052,675)

$

1,745,429

Interest Expense, net

8,307,369

7,745,854

Provision for Income Taxes

3,984,154

4,662,178

Other (Income) Expense, net of Interest Expense

1,052,223

(8,503,501)

Depreciation & Amortization

5,618,834

6,612,814

Earnings Before Interest, Taxes, Depreciation and

Amortization (EBITDA) (non-GAAP)

$

2,909,905

$

12,262,774

Non-Cash Stock Compensation

253,916

214,544

Deal Related Expenses

637,761

1,195,802

Capital Raise Related Expenses

20,760

35,068

Severance

484,561

118,436

Retention Program Expenses

807,500

280,632

Pre-Operating & Dark Carry Expenses

1,053,837

391,917

One-Time Legal Settlements

417,653

Other Non-Recurring Items

754,751

25,707

Adjusted EBITDA (non-GAAP)

$

7,340,644

$

14,524,880

Revenue

41,600,993

40,000,936

Adjusted EBITDA Percent

17.6 %

36.3 %

View original content:https://www.prnewswire.co.uk/news-releases/schwazze-announces-first-quarter-2024-financial-results-302146858.html

Continue Reading
Advertisement

Latest news

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania